Related references
Note: Only part of the references are listed.Glycerol-3-phosphate is an FGF23 regulator derived from the injured kidney
Petra Simic et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
The role of NLRP3 inflammasome in infection-related, immune-mediated and autoimmune skin diseases
Dan Wang et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2020)
A Critical Role of the IL-1 beta-IL-1R Signaling Pathway in Skin Inflammation and Psoriasis Pathogenesis
Yihua Cai et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2019)
Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors
Yang Yang et al.
CELL DEATH & DISEASE (2019)
Integrative metabolomics reveals unique metabolic traits in Guillain-Barre Syndrome and its variants
Soo Jin Park et al.
SCIENTIFIC REPORTS (2019)
Metabolic Biomarkers In Midtrimester Maternal Plasma Can Accurately Predict Adverse Pregnancy Outcome in Patients with SLE
Seung Mi Lee et al.
SCIENTIFIC REPORTS (2019)
Psoriasis: Keratinocytes or Immune Cells - Which Is the Trigger?
Farida Benhadou et al.
DERMATOLOGY (2019)
LPA Induces Keratinocyte Differentiation and Promotes Skin Barrier Function through the LPAR1/LPAR5-RHO-ROCK-SRF Axis
Akiko Sumitomo et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2019)
The role of lysophosphatidic acid in the physiology and pathology of the skin
Li Lei et al.
LIFE SCIENCES (2019)
Cell type-selective pathways and clinical associations of lysophosphatidic acid biosynthesis and signaling in the ovarian cancer microenvironment
Silke Reinartz et al.
MOLECULAR ONCOLOGY (2019)
Monocytes/Macrophages play a pathogenic role in IL-23 mediated psoriasis-like skin inflammation
Yibing Wang et al.
SCIENTIFIC REPORTS (2019)
The NLRP3 inflammasome: molecular activation and regulation to therapeutics
Karen V. Swanson et al.
NATURE REVIEWS IMMUNOLOGY (2019)
Murine models of psoriasis and their usefulness for drug discovery
Shih-Yi Chuang et al.
EXPERT OPINION ON DRUG DISCOVERY (2018)
IL-1β Production by Intermediate Monocytes Is Associated with Immunopathology in Cutaneous Leishmaniasis
Daniela Santos et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)
The interleukin-23/interleukin-17 Axis Links Adaptive and innate immunity in Psoriasis
Michael P. Schoen et al.
FRONTIERS IN IMMUNOLOGY (2018)
T Cell Hierarchy in the Pathogenesis of Psoriasis and Associated Cardiovascular Comorbidities
Fabio Casciano et al.
FRONTIERS IN IMMUNOLOGY (2018)
The Interplay Between Keratinocytes and Immune Cells in the Pathogenesis of Psoriasis
Cristina Albanesi et al.
FRONTIERS IN IMMUNOLOGY (2018)
Discovery of the IL-23/IL-17 Signaling Pathway and the Treatment of Psoriasis
Jason E. Hawkes et al.
JOURNAL OF IMMUNOLOGY (2018)
GPCRs in NLRP3 Inflammasome Activation, Regulation, and Therapeutics
Tiantian Tang et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2018)
Expression of NLPR3 in Psoriasis Is Associated with Enhancement of Interleukin-1β and Caspase-1
Fei Su et al.
MEDICAL SCIENCE MONITOR (2018)
Lysophosphatidic acid-induced itch is mediated by signalling of LPA5 receptor, phospholipase D and TRPA1/TRPV1
Hiroki Kittaka et al.
JOURNAL OF PHYSIOLOGY-LONDON (2017)
Lysophosphatidic acid receptors (LPARs): Potential targets for the treatment of neuropathic pain
Maria Velasco et al.
NEUROPHARMACOLOGY (2017)
Lipidomics profiling reveals the role of glycerophospholipid metabolism in psoriasis
Chunwei Zeng et al.
GIGASCIENCE (2017)
BAY 11-7082 inhibits the NF-κB and NLRP3 inflammasome pathways and protects against IMQ-induced psoriasis
Natasha Irrera et al.
CLINICAL SCIENCE (2017)
Lysophosphatidic acid converts monocytes into macrophages in both mice and humans
Rashmi Ray et al.
BLOOD (2017)
Molecular mechanisms regulating NLRP3 inflammasome activation
Eun-Kyeong Jo et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2016)
Targeting CD8+ T cells prevents psoriasis development
Paola Di Meglio et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
1-Oleyl-lysophosphatidic acid (LPA) promotes polarization of BV-2 and primary murine microglia towards an M1-like phenotype
Ioanna Plastira et al.
JOURNAL OF NEUROINFLAMMATION (2016)
Mechanism and Regulation of NLRP3 Inflammasome Activation
Yuan He et al.
TRENDS IN BIOCHEMICAL SCIENCES (2016)
Promising Pharmacological Directions in the World of Lysophosphatidic Acid Signaling
Nicole C. Stoddard et al.
BIOMOLECULES & THERAPEUTICS (2015)
Resveratrol Ameliorates Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice
Thomas Nordstrom Kjaer et al.
PLOS ONE (2015)
Immunology of Psoriasis
Michelle A. Lowes et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 32 (2014)
Thematic Review Series: Lysophospholipids and their Receptors LPA receptor signaling: pharmacology, physiology, and pathophysiology
Yun C. Yung et al.
JOURNAL OF LIPID RESEARCH (2014)
LipidBlast in silico tandem mass spectrometry database for lipid identification
Tobias Kind et al.
NATURE METHODS (2013)
Selective non-lipid modulator of LPA5 activity in human platelets
Detlef H. Kozian et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Depletion of antigen-presenting cells by clodronate liposomes reverses the psoriatic skin phenotype in KC-Tie2 mice
N. L. Ward et al.
BRITISH JOURNAL OF DERMATOLOGY (2011)
\Generation of Mature Murine Monocytes from Heterogeneous Bone Marrow and Description of Their Properties
Alexander Francke et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2011)
LPA5 Is Abundantly Expressed by Human Mast Cells and Important for Lysophosphatidic Acid Induced MIP-1β Release
Anders Lundequist et al.
PLOS ONE (2011)
LPA Receptors: Subtypes and Biological Actions
Ji Woong Choi et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2010)
A Subpopulation of CD163-Positive Macrophages Is Classically Activated in Psoriasis
Judilyn Fuentes-Duculan et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid Receptor Nomenclature
Jerold Chun et al.
PHARMACOLOGICAL REVIEWS (2010)
Innate IL-17-producing cells: the sentinels of the immune system
Daniel J. Cua et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Cutting Edge: NF-κB Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression
Franz G. Bauernfeind et al.
JOURNAL OF IMMUNOLOGY (2009)
Key Role of Macrophages in the Pathogenesis of CD18 Hypomorphic Murine Model of Psoriasis
Honglin Wang et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Mechanisms of Disease: Psoriasis.
Frank O. Nestle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
The NLR gene family: A standard nomenclature
Jenny P. -Y. Ting et al.
IMMUNITY (2008)
The lysophosphatidic acid receptor LPA(1) links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak
Andrew M. Tager et al.
NATURE MEDICINE (2008)
Psoriasis 1 - Pathogenesis and clinical features of psoriasis
Christopher E. M. Griffiths et al.
LANCET (2007)
The evaluation of psoriasis therapy with biologics leads to a revision of the current view of the pathogenesis of this disorder
Sandra Philipp et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2006)
GPR92 as a new G12/13- and Gq-coupled lysophosphatidic acid receptor that increases cAMP, LPA5
Chang-Wook Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Activated macrophages are essential in a murine model for T cell-mediated chronic psoriasiform skin inflammation
Honglin Wang et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Pathogenic role for skin macrophages in a mouse model of keratinocyte-induced psoriasis-like skin inflammation
Athanasios Stratis et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Lysophosphatidic acid binds to and activates GPR92, a G protein-coupled receptor highly expressed in gastrointestinal lymphocytes
Knut Kotarsky et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
The role of T cells in psoriasis
JC Prinz
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2003)
Share Paper
